Today in Science: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.

Press releases published on September 1, 2026

Sep. 1, 2026

CDT Appoints Co-Founder James Bligh as Chief Executive Officer to Lead Next Phase of Growth

Indeterminate GlobeNewswire

Sep. 1, 2026

Rezolve Ai Reports $130.8 Million H1 Revenue, Up Nearly 21-Fold, as Google Validates Its Infrastructure Strategy for the Agentic Economy

Indeterminate GlobeNewswire

Sep. 1, 2026

Biometric Identity Security Provider BIO-key Participates at H.C. Wainwright Global Investment Conference Sept. 15th and 17th

Indeterminate GlobeNewswire

Sep. 1, 2026

Emergent BioSolutions Awarded Contract Modification Valued at Approximately $24 Million for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)

Indeterminate GlobeNewswire

Sep. 1, 2026

Applied Biologics Activates First Clinical Site in Phase 3 BIOxHEAL™ Trial

Indeterminate GlobeNewswire

Sep. 1, 2026

3 E Network Secures $1.2 Million Enterprise DDR4 Memory Sales Order

Indeterminate GlobeNewswire

Sep. 1, 2026

Kala Bio and Virotek Announce Letter of Intent to Establish an Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program

Indeterminate GlobeNewswire

Sep. 1, 2026

ZenaTech to Showcase Drone as a Service Growth and ZenaDrone Defense Solutions at Series of U.S. and Global Investor and Defense Events

Indeterminate GlobeNewswire

Sep. 1, 2026

NorthStrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four Novel AI-Discovered Compounds Toward Lead Nomination for Potential Cardiac Disease and Obesity Therapeutic Applications

Indeterminate GlobeNewswire

Sep. 1, 2026

Clearmind Reaches Key Milestone: CMND-100 Phase IIa now Underway for Alcohol Use Disorder Trial, One-Third of Part C Enrolled

Indeterminate GlobeNewswire

Sep. 1, 2026

BridgeBio to Participate in September Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

Pyxis Oncology to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

Ardelyx to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

F2G Announces Posters Accepted for Presentation at Upcoming Medical Meetings

Indeterminate GlobeNewswire

Sep. 1, 2026

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 1, 2026

Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)

Indeterminate GlobeNewswire

Sep. 1, 2026

Alumis Announces Topline Results from Envudeucitinib Phase 2b Trial in Systemic Lupus Erythematosus (SLE)

Indeterminate GlobeNewswire

Sep. 1, 2026

KANZHUN LIMITED Announces Change of Directors’ Executive Positions

Indeterminate GlobeNewswire

Sep. 1, 2026

Arletta Pharma Solutions Appoints Jeannette Jager-van Dijk as Chief Executive Officer

Indeterminate GlobeNewswire

Sep. 1, 2026

Kura Oncology to Participate in Three Investor Conferences in September

Indeterminate GlobeNewswire